rs775613793
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_006361.6(HOXB13):āc.653A>Gā(p.Lys218Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00000959 in 1,459,854 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K218N) has been classified as Uncertain significance.
Frequency
Consequence
NM_006361.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HOXB13 | NM_006361.6 | c.653A>G | p.Lys218Arg | missense_variant | 2/2 | ENST00000290295.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HOXB13 | ENST00000290295.8 | c.653A>G | p.Lys218Arg | missense_variant | 2/2 | 1 | NM_006361.6 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 249850Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135240
GnomAD4 exome AF: 0.00000959 AC: 14AN: 1459854Hom.: 0 Cov.: 31 AF XY: 0.0000124 AC XY: 9AN XY: 726342
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2023 | This variant is present in population databases (rs775613793, gnomAD 0.01%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HOXB13 protein function. ClinVar contains an entry for this variant (Variation ID: 483497). This variant has not been reported in the literature in individuals affected with HOXB13-related conditions. This sequence change replaces lysine, which is basic and polar, with arginine, which is basic and polar, at codon 218 of the HOXB13 protein (p.Lys218Arg). - |
Hereditary cancer-predisposing syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 01, 2024 | The p.K218R variant (also known as c.653A>G), located in coding exon 2 of the HOXB13 gene, results from an A to G substitution at nucleotide position 653. The lysine at codon 218 is replaced by arginine, an amino acid with highly similar properties. In one study, that used in silico tools, this variant was predicted to be highly deleterious and damaging to the HOXB13 homeobox protein structure (Chandrasekaran G et al. Chem Biol Drug Des. 2017 Jan;[Epub ahead of print]). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at